The impacts of medication shortages on patient outcomes: A scoping review

Jonathan Phuong · Jonathan H-D Penm · Betty Bouad Chaar · Lachlan Oldfield · Rebekah Jane Moles

253 citations0/0 files storedPLoS ONE

No readable copy stored yet — this record is metadata only.

No open-access location is known for this record yet.

Literature note Cite in a project Citation map

Pharmaceutical Economics and Policy Pharmacy and Medical Practices Pharmaceutical Quality and Counterfeiting

Abstract

BACKGROUND: In recent years, medication shortages have become a growing worldwide issue. This scoping review aimed to systematically synthesise the literature to report on the economic, clinical, and humanistic impacts of medication shortages on patient outcomes. METHODS: Medline, Embase, Global Health, PsycINFO and International Pharmaceutical Abstracts were searched using the two key concepts of medicine shortage and patient outcomes. Articles were limited to the English language, human studies and there were no limits to the year of publication. Manuscripts included contained information regarding the shortage of a scheduled medication and had gathered data regarding the economic, clinical, and/or humanistic outcomes of drug shortages on human patients. FINDINGS: We found that drug shortages were predominantly reported to have adverse economic, clinical and humanistic outcomes to patients. Patients were more commonly reported to have increased out of pocket costs, rates of drug errors, adverse events, mortality, and complaints during times of shortage. There were also reports of equivalent and improved patient outcomes in some cases. CONCLUSIONS: The results of this review provide valuable insights into the impact drug shortages have on patient outcomes. The majority of studies reported medication shortages resulted in negative patient clinical, economic and humanistic outcomes.

Paper brief

Loading…

Cite this work

Citation unavailable for this work.

BibTeX RIS CSL-JSON

No public copy is stored for this record, so only the metadata is cited.

Citations in this library

Citation map →

Stored only when both papers are in the corpus — 253 citations exist upstream.

References

2009Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement 2009Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement 2009Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement.2004The introduction, methods, results, and discussion (IMRAD) structure: a fifty-year survey.

Cited by

2020Vulnerability of the medical product supply chain: the wake-up call of COVID-19 2021Advancing the understanding of pharmaceutical supply chain resilience using complex adaptive system (CAS) theory 2020New regulatory strategies to manage medicines shortages in Europe 2022Stock-outs of essential medicines among community health workers (CHWs) in low- and middle-income countries (LMICs): a systematic literature review of the extent, reasons, and consequences 2020How to address medicines shortages: Findings from a cross-sectional study of 24 countries 2023Digitalization enhancement in the pharmaceutical supply network using a supply chain risk management approach 2022The pros and cons of reshoring to address the problems of shortages in global pharmaceutical value chains: the case of antibiotics 2022

Explore the map →

Papers that cite the same references — the relational fallback while embeddings are still backfilling.

Imported from OpenAlex (CC0) — nothing here is generated.